BPA Call 36C24923A0030-36C24924N0474
- Not listed
- The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 9 awarded a Blanket Purchase Agreement (BPA) to Therakos, Inc., a foreign-owned for-profit corporation, to provide photopheresis light kits, UVADEX solution, and a photopheresis system. The BPA, which has a potential value of $32,704.56, was awarded on May 28, 2024 and has a completion date of May 31, 2024. Therakos is the prime contractor and there are no mentioned subcontractors....
- The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 awarded a Blanket Purchase Agreement (BPA) to Therakos, Inc., a foreign-owned, for-profit corporation, for the provision of a photopheresis system and associated supplies. The award, valued at $106,524.00, is a firm-fixed price contract with a period of performance through August 5, 2024. Therakos, Inc. is the prime contractor and will be delivering the CELLEX Photopheresis System, UVADEX medication, and related...
- This federal contract award is for a Blanket Purchase Agreement (BPA) order between the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 and Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis products and services. The $106,524.00 firm-fixed price contract is for the provision of the CELLEX Photopheresis System, UVADEX medication, and associated procedural kits and supplies used for extracorporeal photopheresis treatments at VA...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos LLC, a foreign-owned for-profit corporation. The contract has a ceiling value of $111,708.00 and an ultimate completion date of September 22, 2025. The contract is for the provision of the CELLEX Photopheresis System procedural kits, UVADEX (methoxsalen) medication, and related medical equipment, which are used for extracorporeal...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded Therakos, Inc., a foreign-owned for-profit company, a $316,030.86 firm fixed-price purchase order contract to provide photopheresis procedural kits and supplies. The contract, which has no set-aside designation, supports veteran healthcare programs through the delivery of photopheresis system kits, UVADEX medication, and associated supplies to VA medical facilities. This contract award is part of Therakos' larger...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Therakos, Inc., a foreign-owned for-profit organization, to provide photopheresis kits. The $942,580.00 contract has a performance period ending on October 25, 2018 and was awarded on October 26, 2017. Therakos will deliver the photopheresis system kits, UVADEX medication, and associated supplies to VA medical facilities in Tennessee to support veteran healthcare programs....
- This is a firm fixed-price contract awarded by the Veterans Integrated Service Network 9 (VISN 9) of the Department of Veterans Affairs (VA) to Therakos, Inc., a foreign-owned, for-profit corporation specializing in photopheresis medical technology and pharmaceutical products. The contract is for the procurement of CELLEX Photophoresis Procedural Kits, with a ceiling value of $111,708.00 and a completion date of June 27, 2025. This contract is not set aside and is an order under a Blanket...
- This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Therakos, Inc., a foreign-owned, for-profit corporation, to provide Therakos Cellex Photopheresis System procedural kits and light assemblies. The contract, valued at $492,732.00, is a firm fixed-price Purchase Order with economic price adjustment, awarded on November 1, 2018 with a completion date of July 30, 2021. The contract is for the supply of photopheresis system disposables and...
- Therakos, Inc. has been awarded a $53,262 firm fixed price Blanket Purchase Agreement (BPA) call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 to provide photopheresis system light kits, UVADEX medication, and a photopheresis system. The contract has a period of performance through March 27, 2024 to support photopheresis medical procedures at a VA facility located in Hazelwood, Missouri. Therakos holds three existing...
- This is a $181,965.00 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned, for-profit corporation specializing in photopheresis medical technology and pharmaceutical products. The contract is for the emergency purchase of Therakos Photopheresis Kits to support immediate patient care. The contract is not set-aside and has an ultimate completion date of February 5, 2016. Therakos, Inc. holds...
- 36C24923A0030Blanket Purchase Agreement
- 36C24923A0030-36C24924N0474BPA Call
This is a $62,139 firm-fixed price blanket purchase agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned for-profit corporation. The BPA is for the delivery of Therakos' CELLEX Photopheresis System, UVADEX medication, and associated procedural kits and supplies to support extracorporeal photopheresis treatments at VA medical centers. Extracorporeal photopheresis is an FDA-approved apheresis procedure used to treat conditions such as cutaneous T-cell lymphoma and graft-versus-host disease. This BPA does not have any socioeconomic set-aside designation. Therakos is the prime contractor and does not typically utilize subcontractors. The company holds several active indefinite delivery vehicle (IDV) contracts with the VA and other federal agencies to provide its photopheresis products and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.1k | 5/14/24 |